Predicting the Impact of Deleterious Single-Nucleotide Polymorphisms in the p47ING1a Isoform of Human ING1 Gene

Md Oliullah Rafi1, Md Takim Sarker2, Mohammad Ashik Sheikh2

  • 1Department of Microbiology and Hygiene, Bangladesh Agricultural University, Mymensingh, 2202, Bangladesh, bau.edu.bd.

Genetics Research
|June 20, 2026
PubMed
Abstract

Insights

Six nonsynonymous single-nucleotide polymorphisms (nsSNPs) in the p47ING1a tumor suppressor

Area of Science:

  • Cancer biology
  • Molecular genetics
  • Structural biology

Background:

  • The ING1 tumor suppressor, specifically the p47ING1a isoform, plays a role in cellular senescence.
  • Its function is mediated by the plant homeodomain (PHD) zinc-finger, which interacts with the H3K4me3 histone mark.
  • The impact of mutations within the PHD domain on ING1a's tumor-suppressive activity is not well understood.

Purpose of the Study:

  • To identify and structurally analyze deleterious nonsynonymous single-nucleotide polymorphisms (nsSNPs) in the p47ING1a PHD domain.
  • To evaluate the functional consequences of these nsSNPs on ING1a's tumor suppressor function.

Main Methods:

  • Computational screening of 347 missense nsSNPs using 12 tools.
  • Stability, evolutionary conservation, and structural modeling (AlphaFold3, GalaxyRefine) were assessed.
  • Binding effects, post-translational modifications, and protein interaction networks were analyzed.

Main Results:

  • Six high-priority nsSNPs (C358S, C374G, W378G, F379V, S382L, R400P) were identified within the PHD domain (residues 353-402).
  • All six mutations were predicted to destabilize the p47ING1a protein.
  • These nsSNPs are predicted to disrupt H3K4me3 binding and Sin3A/HDAC complex interactions.

Conclusions:

  • Six nsSNPs in the p47ING1a PHD domain may impair its tumor-suppressor function by affecting protein stability and critical interactions.
  • These findings highlight the importance of the PHD domain in ING1a's function and provide a basis for experimental validation.
  • The study suggests potential therapeutic targets at the PHD-H3K4me3 interface.

Related Concept Videos

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...